2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Research Article
You have full text access to this OnlineOpen article
Efficacy of infliximab in resistant psoriatic arthritis
Article first published online: 1 AUG 2003
DOI: 10.1002/art.11201
Copyright © 2003 by the American College of Rheumatology
1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Additional Information
How to Cite
Salvarani, C., Cantini, F., Olivieri, I., Macchioni, P., Padula, A., Niccoli, L., Catanoso, M. G., Scocco, G. L. and Boiardi, L. (2003), Efficacy of infliximab in resistant psoriatic arthritis. Arthritis & Rheumatism, 49: 541–545. doi: 10.1002/art.11201
Publication History
- Issue published online: 1 AUG 2003
- Article first published online: 1 AUG 2003
- Manuscript Accepted: 5 SEP 2002
- Manuscript Received: 7 OCT 2001
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , Combination systemic therapies in psoriatic arthritis, Journal of Dermatological Treatment, 2011, 22, 5, 276
- 2, , , , , , , , , Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis, ReumatologÃa ClÃnica (English Edition), 2011, 7, 3, 179
- 3, , , , , , , , , Documento SER de consenso sobre el uso de terapias biológicas en la artritis psoriásica, ReumatologÃa ClÃnica, 2011, 7, 3, 179
- 4, , , , , , , , , Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel, Rheumatology International, 2010, 32, 3, 595
- 5, , , , , , Psoriatic arthritis: a systematic review, International Journal of Rheumatic Diseases, 2010, 13, 4Direct Link:
- 6, , , , , , , Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti–tumor necrosis factor α therapy: Is there a need for more comprehensive screening procedures?, Arthritis Care & Research, 2009, 61, 6Direct Link:
- 7, , , , , , , , , , , , , The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project, Clinical Rheumatology, 2009, 29, 2, 167
- 8, , , , , Biologicals in rheumatology: Austrian experiences from a rheumatic outpatient clinic, Rheumatology International, 2008, 29, 1, 69
- 9, , , , To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis, Journal of the American Academy of Dermatology, 2008, 58, 6, 970
- 10, , , , A Systematic Review of Measures Used to Assess Chronic Musculoskeletal Pain in Clinical and Randomized Controlled Clinical Trials, The Journal of Pain, 2007, 8, 12, 906
- 11, , , Anti-TNF alpha dans le traitement du rhumatisme psoriasique, La Presse Médicale, 2006, 35, 4, 647
- 12, , Dactylitis: Pathogenesis and clinical considerations, Current Rheumatology Reports, 2006, 8, 5, 338
- 13GuÃas y recomendaciones del Colegio Mexicano de ReumatologÃa para el uso de agentes biológicos en enfermos reumáticos, ReumatologÃa ClÃnica, 2006, 2, 2, 78
- 14, , Infections Associated with Tumor Necrosis Factor-α Antagonists, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005, 25, 9Direct Link:
- 15, , , , , , Successful infliximab therapy of psoriasis vulgaris and psoriatic arthritis in a patient with cirrhosis, British Journal of Dermatology, 2005, 153, 1Direct Link:
- 16
- 17, , Anti-TNF-α therapy in ankylosing spondylitis, Expert Opinion on Pharmacotherapy, 2004, 5, 7, 1497
- 18, , Current and investigational treatment of psoriatic arthritis, Expert Opinion on Investigational Drugs, 2004, 13, 2, 139
- 19, , Psoriasis and its treatment with infliximab-mediated tumor necrosis factor α blockade, Dermatologic Clinics, 2004, 22, 4, 437
- 20, , Psoriatic arthritis: prevalence, diagnosis, and review of therapy for the dermatologist, Dermatologic Clinics, 2004, 22, 4, 477
- 21, , , Recent advances in the treatment of the spondyloarthropathies, Current Opinion in Rheumatology, 2004, 16, 4, 357
- 22, , , Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseases, Current Opinion in Biotechnology, 2004, 15, 6, 557
- 23, Recent Advances in the Treatment of Spondyloarthropathy, Journal of the Korean Medical Association, 2003, 46, 11, 972